The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase

British Journal of Haematology

Volumn 114, Issue 3, 2001, Pages 566-573

  Vinatzer, Ursula ^a   Taplick, Jan ^a   Seiser, Christian ^a   Fonatsch, Christa ^a   Wieser, Rotraud ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chromosome rearrangement; EVI 1; Histone deacetylase; MDS1 EVI1; Myeloid leukaemia

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EVI 1; TRANSCRIPTION FACTOR MDS1 EVI1; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; ENZYME ACTIVITY; HUMAN; IN VITRO STUDY; MAMMAL CELL; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REPORTER GENE;

ANIMALS; CELL LINE; COS CELLS; DNA-BINDING PROTEINS; ELECTROPORATION; ENZYME INHIBITORS; FEMALE; GENE REARRANGEMENT; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; LEUKEMIA; ONCOGENE PROTEINS, FUSION; PREGNANCY; PROTO-ONCOGENES; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0034786463     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02987.x     Document Type: Article

References (55)

1. NuRD and SIN3 histone deacetylase complexes in development
2. The Evi-1 proto-oncogene encodes a transcriptional repressor activity associated with transformation
3. Identification of mouse histone deacetylase 1 as a growth factor-inducible gene
4. The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A
5. Histone deacetylase 1 can repress transcription by binding to Sp1
6. Expression of the Evi-1 gene in myelodysplastic syndromes
7. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family
8. Both TEL and AML-1 contribute repression domains to the t (12; 21) fusion protein
9. Evi-1 expression in leukemic patients with rearrangements of the 3q25-q28 chromosomal region
10. Expression of the transcription factor Evi-1 in human erythroleukemia cell lines and in leukemias
11. The carboxyl domain of zinc fingers of the Evi-1 myeloid transforming gene binds a consensus sequence of GAAGATGAG
12. Expression of the Evi-1 gene in haemopoietic cells of children with juvenile myelomonocytic leukaemia and normal donors
13. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia
14. The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development
15. mSin3a regulates murine erythroleukemia cell differentiation through association with the Tal1 (or Scl) transcription factor
16. The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling
17. Modifying chromatin and concepts of cancer
18. Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F
19. Retroviral insertional activation of the EVI1 oncogene does not prevent G-CSF-induced maturation of the murine pluripotent myeloid cell line 32Dcl3
20. Evi-1 ZF1 DNA binding activity and a second distinct transcriptional repressor region are both required for optimal transformation of Rat1 fibroblasts
21. Histone acetylases and deacetylases in cell proliferation
22. Specificity of signaling by STAT1 depends on SH2-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression
23. Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene
24. The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3
25. The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death
26. Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300
27. Role of the histone deacetylase complex in acute promyelocytic leukaemia
28. Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice
29. Rb interacts with histone deacetylase to repress transcription
30. Transcriptional activation and DNA binding by the erythroid factor GF-1/NF-E1/Eryf 1
31. n sequences
32. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia
33. Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines
34. Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: Sequence of cDNAs and structure of alternatively spliced transcripts
35. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26
36. Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor
37. 1-28 CTCATCTTC
38. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21) (q26;q22) translocations
39. Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia
40. Fusion of ETV6 to MDS1/EVI1 as a result of t(3;12)(q26;p13) in myeloproliferative disorders
41. Zinc fingers 1-7 of EVI1 fail to bind to the GATA motif by itself but require the core site GACAAGATA for binding
42. Chromatin remodeling and leukemia: New therapeutic paradigms
43. Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations
44. The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator
45. MDS1/EVI1 enhances TGF-beta 1 signaling and strengthens its growth-inhibitory effect, but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t (3; 21), abrogates growth-inhibition in response to TGF-beta 1
46. Stra13 expression is associated with growth arrest and represses transcription through histone deacetylase (HDAC) -dependent and HDAC-independent mechanisms
47. Identification of a breakpoint cluster region 30 of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv (3) (q21q26)
48. 3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: Biological and clinical features
49. Cloning and characterization of mCtBP2, a co-repressor that associates with basic Kruppel-like factor and other mammalian transcriptional regulators
50. ETO, fusion partner in t (8; 21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex
51. Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells
52. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase
53. Comparative expression analysis of the antagonistic transcription factors EVI1 and MDS1-EVI1 in murine tissues and during in vitro hematopoietic differentiation
54. Multiple modes of repression by the Smad transcriptional corepressor TGIF
55. Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemia